Sign in

CIK 0002029039 · Non-accelerated filer<br>Emerging growth company

Nasus Pharma Ltd

Sign in to watch
Ticker
NSRX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
other
EIN
516022712
Phone
972 54-255-3956
Business address
29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
  1. 6-K Event Report of Foreign Issuer
  2. UPLOAD Other SEC-generated Letter
  3. 6-K Event Report of Foreign Issuer
  4. F-1 Offering Registration Statement for Certain Foreign Private Issuers
  5. D Other Notice of Sales of Unregistered Securities
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 6-K Event Report of Foreign Issuer

Page 3 of 5 · 100 filings